DFPG INVESTMENTS, LLC - EIGER BIOPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
DFPG INVESTMENTS, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,896
-59.5%
32,4300.0%0.00%
-50.0%
Q2 2023$26,884
-7.6%
32,4300.0%0.00%
-33.3%
Q1 2023$29,086
-32.1%
32,4300.0%0.00%
-57.1%
Q4 2022$42,808
-74.1%
32,4300.0%0.01%
-90.0%
Q3 2022$165,000
-37.5%
32,4300.0%0.07%
-39.1%
Q2 2022$264,000
+24.5%
32,4300.0%0.12%
+38.6%
Q1 2022$212,000
+57.0%
32,4300.0%0.08%
+48.2%
Q4 2021$135,000
-38.4%
32,4300.0%0.06%
-32.5%
Q3 2021$219,000
-18.6%
32,4300.0%0.08%
-18.6%
Q2 2021$269,000
-7.2%
32,4300.0%0.10%
-17.7%
Q1 2021$290,000
-23.5%
32,4300.0%0.12%
-28.7%
Q4 2020$379,00032,4300.17%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$6,144,0004.00%
P.A.W. CAPITAL CORP 380,000$3,363,0002.96%
INTERWEST VENTURE MANAGEMENT CO 764,918$6,770,0001.78%
Telemetry Investments, L.L.C. 150,477$1,332,0001.51%
683 Capital Management, LLC 2,683,600$23,750,0001.26%
KNOTT DAVID M 276,535$2,447,0001.05%
Trellus Management Company, LLC 226,000$2,000,0001.04%
TOWERVIEW LLC 140,000$1,239,0000.77%
Vivo Capital, LLC 1,791,257$15,853,0000.56%
CAXTON CORP 94,083$833,0000.54%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders